檢索結果 - Jacob Aelion
- Showing 1 - 11 results of 11
-
1
-
2
-
3
Early and sustained efficacy with apremilast monotherapy in biological-naïve patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE) 由 Peter Nash, Kamal Ohson, Jessica A. Walsh, Nikolay Delev, Dianne Nguyen, Lichen Teng, Juan J. Gómez‐Reino, Jacob Aelion
出版 2018Artigo -
4
Apremilast, an oral phosphodiesterase 4 inhibitor, in patients with psoriatic arthritis and current skin involvement: a phase III, randomised, controlled trial (PALACE 3) 由 Christopher J Edwards, Francisco J. Blanco, Jeffrey Crowley, C. Birbara, Janusz Jaworski, Jacob Aelion, Randall M. Stevens, Adele R. Vessey, Xiaojiang Zhan, Paul Bird
出版 2016Artigo -
5
-
6
<scp>ABT</scp>‐122, a Bispecific Dual Variable Domain Immunoglobulin Targeting Tumor Necrosis Factor and Interleukin‐17A, in Patients With Rheumatoid Arthritis With an Inadequate R... 由 Mark C. Genovese, Michael E. Weinblatt, Jacob Aelion, Heikki Mansikka, Paul M. Peloso, Kun Chen, Yihan Li, Mohamed I. A. Othman, Amit Khatri, Nasser Khan, Robert J. Padley
出版 2018Artigo -
7
Efficacy and Safety of <scp>ABBV</scp>‐3373, a Novel Anti–Tumor Necrosis Factor Glucocorticoid Receptor Modulator Antibody–Drug Conjugate, in Adults with <scp>Moderate‐to‐Severe</s... 由 Frank Buttgereit, Jacob Aelion, Bernadette Rojkovich, Anna Zubrzycka‐Sienkiewicz, Su Chen, Yang� Yang, Dilek Arikan, Ronilda D’Cunha, Yinuo Pang, H. Küpper, Timothy R. D. J. Radstake, Howard Amital
出版 2022Artigo -
8
One-year Efficacy and Safety Results of Secukinumab in Patients With Rheumatoid Arthritis: Phase II, Dose-finding, Double-blind, Randomized, Placebo-controlled Study 由 Mark C. Genovese, Patrick Durez, Hanno B. Richards, Jerzy Supronik, Eva Dokoupilová, Jacob Aelion, Sang‐Heon Lee, Christine E. Codding, Herbert Kellner, Takashi Ikawa, Sophie Hugot, Gregory Ligozio, Shephard Mpofu
出版 2014Artigo -
9
Dual inhibition of tumour necrosis factor and interleukin-17A with ABT-122: open-label long-term extension studies in rheumatoid arthritis or psoriatic arthritis 由 Mark C. Genovese, Michael E. Weinblatt, Philip J. Mease, Jacob Aelion, Paul M. Peloso, Kun Chen, Yihan Li, John Liu, Mohamed I. A. Othman, Amit Khatri, Heikki Mansikka, Piotr Leszczyński
出版 2018Artigo -
10
Efficacy and safety of risankizumab for active psoriatic arthritis: 24-week results from the randomised, double-blind, phase 3 KEEPsAKE 2 trial 由 Andrew J.K. Östör, Filip Van den Bosch, Kim Papp, Cecilia Asnal, Ricardo Blanco, Jacob Aelion, Gabriela Alperovich, Wenjing Lü, Zailong Wang, Ahmed M. Soliman, Ann Eldred, Lisa Barcomb, Alan Kivitz
出版 2021Artigo -
11
Tocilizumab in systemic sclerosis: a randomised, double-blind, placebo-controlled, phase 3 trial 由 Dinesh Khanna, Celia J. F. Lin, Daniel E. Furst, Jonathan Goldin, Grace Kim, Masataka Kuwana, Yannick Allanore, Marco Matucci‐Cerinic, Oliver Distler, Yoshihito Shima, Jacob M. van Laar, Helen Spotswood, Bridget K. Wagner, Jeffrey Siegel, Angelika Jahreis, Christopher P. Denton, Eleonora Lucero, Bernardo A. Pons‐Estel, Mariano Rivero, Guillermo Tate, Vanessa Smith, Ellen De Langhe, Rasho Rashkov, Anastas Batalov, I Goranov, Румен Стоилов, James V. Dunne, Sindhu R. Johnson, Janet Pope, Dušanka Martinović Kaliterna, Mette Mogensen, Anne Braae Olesen, Yannick Allanore, J. Henes, Ulf Müller‐Ladner, Gabriela Riemekasten, Alla Skapenko, Panayiotis G. Vlachoyiannopoulos, Emese Kiss, Tünde Minier, Lorenzo Beretta, Elisa Gremese, Marco Matucci‐Cerinic, Gabriele Valentini, Yoshihide Asano, Tatsuya Atsumi, Hironobu Ihn, Tomonori Ishii, Osamu Ishikawa, Masataka Kuwana, Yoshihito Shima, Hiroki Takahashi, Kazuhiko Takehara, Yoshiya Tanaka, Yoshioki Yamasaki, Loreta Bukauskienė, İrena Butrimienė, Gabriel Medrano Ramírez, Cesar Ramos‐Remus, Tatiana Sofía Rodríguez Reyna, Jeska de Vries‐Bouwstra, Jacob M. van Laar, Bogdan Batko, Sławomir Jeka, Eugeniusz J. Kucharz, Maria Majdan, Marzena Olesiñska, Żaneta Smoleńska, José Delgado Alves, María José Santos, C. Mihai, Simona Rednic, I. Castellví, Francisco Longo, C Simeόn Aznar, Patrícia Carreira, Oliver Distler, Ulrich A. Walker, Emma Derrett‐Smith, Bridget Griffiths, Neil D McKay, Christopher P. Denton, Jacob Aelion, Michael Borofsky, Roy Fleischmann, Joseph Z. Forstot, Daniel E. Furst, Suzanne Kafaja, Mahmuda Khan, Dinesh Khanna, Michael Kohen, Richard W. Martin, Fabian Mendoza-Ballesteros, Alireza Nami, Shirley Pang, Grissel Ríos, Robert W. Simms, Keith M. Sullivan, Virginia Steen
出版 2020Artigo
相關主題
Medicine
Internal medicine
Psoriatic arthritis
Alternative medicine
Immunology
Pathology
Placebo
Randomized controlled trial
Rheumatoid arthritis
Arthritis
Dermatology
Psoriasis
Adverse effect
Apremilast
Gastroenterology
Bacteria
Biology
Clinical endpoint
Double blind
Genetics
Immune system
Methotrexate
Psoriasis Area and Severity Index
Rheumatology
Staphylococcus aureus
Streptococcus pyogenes
Superantigen
T cell
T-cell receptor
Adalimumab